Genotyping of AR and PSA polymorphisms in a patient with Klinefelter syndrome, non-Hodgkin lymphoma, and adenocarcinoma of the prostate

Cancer Genetics and Cytogenetics

Volumn 153, Issue 2, 2004, Pages 165-169

  Mattos Dos Santos, Rodrigo ^a   Aparecida Rainho, Claudia ^a   Carlos Souza Trindade, José ^a   Carlos Souza Trindade Filho, José ^a   Lauro Viana De Camargo, João ^a   Regina Rogatto, Silvia ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER RISK; CASE REPORT; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; KLINEFELTER SYNDROME; MALE; METHYLATION; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; X CHROMOSOME;

ADENOCARCINOMA; GENOTYPE; HUMANS; KLINEFELTER SYNDROME; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SEX CHROMOSOME ABERRATIONS;

EID: 9944250835     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.01.002     Document Type: Article

References (21)

1. Xu J., Meyers D.A., Freije D., Isaacs S., Wiley K., Nusskern D., Ewing C., Wilkens E., Bujnovszky P., Bova G.S., Walsh P., Isaacs W., Schleutker J., Matikainen M., Tammela T., Visakorpi T., Kallioniemi O.P., Berry R., Schaid D., French A., McDonnell S., Schroeder J., Blute M., Thibodeau S., Trent J. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet. 20:1998;175-179
2. Lange E.M., Chen H., Brierley K., Perrone E.E., Bock C.H., Gillanders E., Ray M.E., Cooney K.A. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX. Clin Cancer Res. 5:1999;4013-4020
3. Greenberg N.M. Androgens and growth factors in prostate cancer: a transgenic perspective. Prostate Cancer Prostatic Dis. 3:2000;224-228
4. Ross R.K., Pike M.C., Coetzee G.A., Reichardt J.K., Yu M.C., Feigelson H., Stanczyk F.Z., Kolonel L.N., Henderson B.E. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res. 58:1998;4497-4504
5. Giovannucci E. Is the androgen receptor CAG repeats length significant for prostate cancer? Cancer Epidemiol Biomarkers Prev. 11:2002;985-986
6. Rao A., Cramer S.D. Identification of a polymorphism in the ARE1 region of the PSA promoter. Proc Am Assoc Cancer Res. 40:1999;65
7. Xue W., Irvine R.A., Yu M.C., Ross R.K., Coetzee G.A., Ingles S.A. Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci. Cancer Res. 60:2000;839-841
8. Verma R.S., Babu A. Chromosomes in clinical medicine. Human chromosomes: principles and techniques. 2nd edition:1995;362-409 McGraw-Hill, New York
9. Jones K.L. Smith's recognizable patters of human malformation. 5th edition:1997;W.B. Saunders Co, Philadelphia
10. Hasle H., Mellemgaard A., Nielsen J., Hansen J. Cancer incidence in men with Klinefelter syndrome. Br J Cancer. 71:1995;416-420
11. Swerdlow A.J., Hermon C., Jacobs P.A., Alberman E., Beral V., Daker M., Fordyce A., Youngs S. Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann Hum Genet. 65:2001;177-188
12. Bharaj B.S., Vassilikis E.J.K., Diamandis E.P. Rapid and accurate determination of (CAG) repeats in the androgen receptor gene using polymerase chain reaction and automated fragment analysis. Clin Biochem. 32:1999;327-332
13. Allen R.C., Zoghbi H.Y., Moseley A.B., Rosenblatt H.M., Belmont J.W. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet. 51:1992;1229-1239
14. Chitnis S., Monteiro J., Glass D., Apatoff B., Salmon J., Concannon P., Gregersen P.K. The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res. 2:2000;399-406
15. Brown C.J., Robinson W.P. The causes and consequences of random and non-random X chromosome inactivation in humans. Clin Genet. 58:2000;353-363
16. Geraedts J.P., Ford C.E., Briet E., Hartgrink-Groeneveld C.A., den Ottolander G.J. Klinefelter syndrome: predisposition to acute non-lymphocytic leukemia? Lancet. 1:1980;1092
17. Feldman B.J., Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer. 1:2001;34-45
18. Simental J.A., Sar M., Lane M.V., French F.S., Wilson E.M. Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem. 266:1991;510-518
19. Irvine R.A., Yu M.C., Ross R.K., Coetzee G.A. The CAG and GGC microssatellites of androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res. 55:1995;1937-1940
20. Chamberlain N.C., Driver E.D., Miesfeld R.L. The length and location of CAG trinucleotide repeat in androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 22:1994;3181-3186
21. Gsur A., Prayer M., Haidinger G., Zidek T., Madersbacher S., Schatzl G., Marberger M., Vutuc C., Micksche M. Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk. Carcinogenesis. 23:2002;1647-1651